Koshi Hashimoto
Overview
Explore the profile of Koshi Hashimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
136
Citations
1491
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Takizawa H, Uchida T, Suzuki N, Onose H, Yamada E, Hashimoto K, et al.
Endocr J
. 2025 Feb;
PMID: 39993757
Inorganic iodine has long been used as a treatment for Graves' disease. It is currently a treatment option for mild Graves' disease, but there have been no data suggesting the...
2.
Matsumoto N, Otomaru M, Asai K, Hara K, Tsuchiya T, Takebayashi K, et al.
Intern Med
. 2025 Feb;
PMID: 39971300
The causes of hypercalcemia vary. There are high-calcium-containing preparations in Chinese herbal medicine, which may contribute to drug-induced hypercalcemia. We encountered a case of hypercalcemia following the simultaneous administration of...
3.
Takebayashi K, Suzuki T, Yamauchi M, Hara K, Tsuchiya T, Inukai T, et al.
Intern Med
. 2024 Aug;
64(5):643-649.
PMID: 39111892
Objective The main purpose of this study was to evaluate the associations between circulating angiopoietin-like protein 6 (ANGPTL6) levels and various diabetes- and atherosclerosis-related variables in patients with type 2...
4.
Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K
Cureus
. 2024 Jul;
16(7):e64444.
PMID: 39007025
Aim: The main purpose of the current study was to investigate the effect of season change and the influence of the COVID-19 pandemic on the ratio of glycoalbumin to hemoglobin...
5.
Takebayashi K, Yamauchi M, Hara K, Tsuchiya T, Hashimoto K
Cureus
. 2024 Jul;
16(7):e63942.
PMID: 38974395
Renal anemia is generally caused by a decrease in the production of erythropoietin in kidney due to renal dysfunction, and this may be associated with the increase in mortality and...
6.
Shinozaki H, Kawai S, Gamo-Kawasaki M, Takei A, Tsujikado K, Fukuda K, et al.
Endocr J
. 2024 Jun;
71(9):907-924.
PMID: 38910123
Fibroblast growth factor (FGF) 21, a hormone produced by the liver, improves glucose and lipid metabolism. We recently demonstrated that the FGF21 gene (Fgf21) underwent DNA demethylation in the mouse...
7.
Tanaka S, Akagawa H, Azuma K, Higuchi S, Ujiie A, Hashimoto K, et al.
Clin Genet
. 2024 May;
106(3):293-304.
PMID: 38733153
Maturity-Onset Diabetes of the Young (MODY) is a diabetes mellitus subtype caused by a single gene. The detection rate of the responsible gene is 27% in the United Kingdom, indicating...
8.
Manaka K, Kato S, Sakamoto R, Yamakage H, Uema T, Kawai S, et al.
Endocr J
. 2024 Mar;
71(5):499-514.
PMID: 38462511
We investigated the impact of the Coronavirus disease 2019 (COVID-19) pandemic on the management of endocrine and metabolic disorders in Japan. We conducted a cross-sectional nationwide questionnaire survey targeting board-certified...
9.
Hara K, Ujiie A, Suzuki S, Okumura T, Kubo M, Shinozaki H, et al.
Endocr J
. 2023 Nov;
71(1):39-44.
PMID: 38030260
We encountered five cases that exhibited false-high Hemoglobin A1c (HbA1c) levels when samples were examined using the enzyme-based NORUDIA N HbA1c kit. HbA1c levels were higher than those obtained using...
10.
Kawai S, Yamakage H, Kotani K, Noda M, Satoh-Asahara N, Hashimoto K
Endocr J
. 2023 Oct;
70(12):1175-1186.
PMID: 37793817
Metabolically Healthy Obesity (MHO) is generally recognized as the absence of any metabolic disorders and cardiovascular diseases, including type 2 diabetes, dyslipidemia, and hypertension, in obese individuals; however, it is...